National Taiwan University Hospital: Hepatitis C, Chronic trials
The registry lists 15 Hepatitis C, Chronic studies with National Taiwan University Hospital as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 3 1Phase 4 6No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected PatientsCompletedNCT00495131Phase 4Results posted
- Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis CCompletedNCT00491244Phase 4Results posted
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose RibavirinCompletedNCT00491179Phase 4Results posted
- Effects of Activity and Education Program on Patients With Chronic Hepatitis C InfectionStatus unknownNCT01572233Not applicable
- Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin TreatmentsStatus unknownNCT01178749
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
- Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis CStatus unknownNCT00980161
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in TaiwanStatus unknownNCT00543244
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVRCompletedNCT00532701Phase 4
- Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesCompletedNCT00466336
- Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation StudyCompletedNCT00466271
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3